Anti-N-Methyl d-Aspartate Receptor Encephalitis and Electroconvulsive Therapy: Literature Review and Future Directions
- PMID: 30389078
- DOI: 10.1016/j.chc.2018.07.005
Anti-N-Methyl d-Aspartate Receptor Encephalitis and Electroconvulsive Therapy: Literature Review and Future Directions
Abstract
Despite the majority of patients with anti-N-methyl d-aspartate receptor (NMDAR) antibody encephalitis presenting with catatonic symptoms, the literature has not focused on well-known treatments for catatonia, such as electroconvulsive therapy (ECT). The authors review the literature identifying case reports that document the effective use of ECT for anti-NMDAR encephalitis. They also identify gaps in the literature regarding use and documentation of ECT and review possible mechanisms of action for ECT. The authors propose identifying catatonia as a syndrome with multiple potential causes (including anti-NMDAR encephalitis) and suggest a standardized treatment approach using evidence-based catatonia treatments such as ECT and benzodiazepines.
Keywords: Anti-NMDA encephalitis; Autoimmune encephalitis; Catatonia; ECT; Electroconvulsive therapy.
Copyright © 2018 Elsevier Inc. All rights reserved.
Similar articles
-
Electroconvulsive therapy for anti-N-methyl-d-aspartate (NMDA) receptor encephalitis: A systematic review of cases.Brain Stimul. 2019 Mar-Apr;12(2):329-334. doi: 10.1016/j.brs.2018.11.016. Epub 2018 Dec 4. Brain Stimul. 2019. PMID: 30528383
-
Pediatric anti-NMDA receptor encephalitis with catatonia: treatment with electroconvulsive therapy.Pediatr Rheumatol Online J. 2019 Feb 18;17(1):8. doi: 10.1186/s12969-019-0310-0. Pediatr Rheumatol Online J. 2019. PMID: 30777097 Free PMC article.
-
Electroconvulsive therapy for catatonia in anti-NMDA receptor encephalitis: A case series.J Neuroimmunol. 2024 Jan 15;386:578271. doi: 10.1016/j.jneuroim.2023.578271. Epub 2023 Dec 22. J Neuroimmunol. 2024. PMID: 38155066
-
Adolescents and Young Adults With Anti-N-methyl-D-aspartate Receptor Encephalitis With Excited Catatonia: Literature Review and 2 Illustrative Cases.J Acad Consult Liaison Psychiatry. 2023 Mar-Apr;64(2):177-182. doi: 10.1016/j.jaclp.2022.07.006. Epub 2022 Aug 7. J Acad Consult Liaison Psychiatry. 2023. PMID: 35948253 Review.
-
Electroconvulsive Therapy in Anti-N-Methyl-D-Aspartate Receptor Encephalitis: A Case Report and Review of the Literature.J ECT. 2016 Dec;32(4):225-229. doi: 10.1097/YCT.0000000000000334. J ECT. 2016. PMID: 27295461 Review.
Cited by
-
Developing Consensus in the Assessment and Treatment Pathways for Autoimmune Encephalitis in Child and Adolescent Psychiatry.Front Psychiatry. 2021 Mar 29;12:638901. doi: 10.3389/fpsyt.2021.638901. eCollection 2021. Front Psychiatry. 2021. PMID: 33854451 Free PMC article.
-
Electroconvulsive therapy and seizure: a double-edged sword?Encephalitis. 2023 Oct;3(4):103-108. doi: 10.47936/encephalitis.2023.00059. Epub 2023 Jul 13. Encephalitis. 2023. PMID: 37621189 Free PMC article.
-
Catatonia in anti-NMDA receptor encephalitis: a case series and approach to improve outcomes with electroconvulsive therapy.BMJ Neurol Open. 2024 Nov 12;6(2):e000812. doi: 10.1136/bmjno-2024-000812. eCollection 2024. BMJ Neurol Open. 2024. PMID: 39564516 Free PMC article.
-
Rethinking Clozapine: Lights and Shadows of a Revolutionary Drug.Brain Sci. 2024 Jan 20;14(1):103. doi: 10.3390/brainsci14010103. Brain Sci. 2024. PMID: 38275523 Free PMC article. Review.
-
Complete cognitive recovery in a severe case of anti-N-methyl-d-aspartate receptor encephalitis treated with electroconvulsive therapy.BMJ Case Rep. 2020 Feb 6;13(2):e233772. doi: 10.1136/bcr-2019-233772. BMJ Case Rep. 2020. PMID: 32034002 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources